Your browser doesn't support javascript.
loading
Mammalian cell expressed recombinant trimeric spike protein is a potent vaccine antigen and confers near-complete protection against SARS-CoV-2 infection in Hamster.
Vikram Kumar, B; Singh, Sneha; Verma, Geetika; Kumar, Reetesh; Mishra, Pranaya M; Kumar, Sahil; Nagaraj, Santhosh K; Nag, Joydeep; Joy, Christy M; Nikam, Bhushan; Singh, Dharmendra; Kalidas, Nidhi; Singh, Shubham; Bhardwaj, Ashwani K; Mankotia, Dhananjay S; Ringe, Rajesh P; Gupta, Nimesh; Tripathi, Shashank; Mishra, Ravi P N.
Affiliation
  • Jitender; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
  • Vikram Kumar B; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
  • Singh S; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
  • Verma G; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
  • Kumar R; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
  • Mishra PM; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
  • Kumar S; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
  • Nagaraj SK; Centre for Infectious Disease Research, Indian Institute of Science, Bengaluru, India.
  • Nag J; Centre for Infectious Disease Research, Indian Institute of Science, Bengaluru, India.
  • Joy CM; Centre for Infectious Disease Research, Indian Institute of Science, Bengaluru, India.
  • Nikam B; National Institute of Immunology, New Delhi, India.
  • Singh D; National Institute of Immunology, New Delhi, India.
  • Pooja; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
  • Kalidas N; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
  • Singh S; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
  • Mumtaz; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
  • Bhardwaj AK; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
  • Mankotia DS; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
  • Ringe RP; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India.
  • Gupta N; National Institute of Immunology, New Delhi, India.
  • Tripathi S; Centre for Infectious Disease Research, Indian Institute of Science, Bengaluru, India; Microbiology & Cell Biology Department, Indian Institute of Science, Bengaluru, India.
  • Mishra RPN; Vaccine & Biotherapeutics Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India. Electronic address: ravi.mishra@imtech.res.in.
Vaccine ; 42(20): 126099, 2024 Aug 13.
Article in En | MEDLINE | ID: mdl-38981743
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral Limits: Animals / Female / Humans Language: En Journal: Vaccine Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral Limits: Animals / Female / Humans Language: En Journal: Vaccine Year: 2024 Document type: Article Affiliation country: Country of publication: